CompletedPhase 3NCT03277690

A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.

Studying OBSOLETE: Cushing syndrome

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Cortendo AB
Principal Investigator: Xavier Valencia, MD
Cortendo AB
Intervention: Levoketoconazole(drug)
Enrollment: 84 enrolled
Eligibility: 18 years · All sexes
Timeline: 2017 – 2020

Study locations (30)

Keck Medical Center University of Southern California HCII, Internal Medicine - Keck Hospital, Los Angeles, California, United States
Cedars-Sinai Medical Center, Cedars-Sinai Pituitary Center, Los Angeles, California, United States
UCLA School of Medicine, Medicine/Endocrinology Department, Los Angeles, California, United States
The Center for Diabetes and Endocrine Care, Fort Lauderdale, Florida, United States
Emory University, Neurosurgery, Atlanta, Georgia, United States
Northwestern University, Medicine - Endocrinology, Chicago, Illinois, United States
Johns Hopkins University, Endocrinology Department, Baltimore, Maryland, United States
University of Michigan, Comprehensive Endocrine Research, Internal Medicine - MEND, Ann Arbor, Michigan, United States
Washington University School of Medicine, Endocrinology, St Louis, Missouri, United States
Columbia University, College of P&S Medicine/Neuro-endocrine Unit, New York, New York, United States
Memorial Sloan Kettering Cancer Center, Endocrinology, New York, New York, United States
Oregon Health & Science University, Neurological Surgery, Portland, Oregon, United States
Allegheny Neuroendocrinology Center, West Penn Allegheny Health System, Pittsburgh, Pennsylvania, United States
Alexandovska University Hospital, Clinic of Endocrinology & Metabolic Diseases, Sofia, Bulgaria
University Multiprofile Hospital for Active Treatment "Aleksandrovska" EAD Clinic of Endocrinology and Metabolic Diseases, Sofia, Bulgaria
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03277690 on ClinicalTrials.gov

Other trials for OBSOLETE: Cushing syndrome

Additional recruiting or active studies for the same condition.

See all trials for OBSOLETE: Cushing syndrome →

← Back to all trials